Professional
Added to YB: 2025-02-11
Pitch date: 2024-12-31
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+89.24%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments.
Market Cap
EUR 28.5B
Pitch Price
EUR 19.21
Price Target
N/A
Dividend
0.38%
EV/EBITDA
7.40
P/E
-144.19
EV/Sales
1.33
Sector
Pharmaceuticals
Category
turnaround
Show full summary:
Oakmark Global All Cap Strategy Portfolio Holding: Bayer
BAYN.DE: Stock down on PCB litigation review & soft 2025 guidance. Crop protection profit decline disappointing. New CEO's restructuring may offset pressures. Well-positioned franchises have potential. Watching for evidence of success in Anderson's strategy Year 2.
Read full article (1 min)